Global Disease Outbreaks: A 2025 Snapshot and Implications for the U.S.

Published: Oct 29, 2025

Each year, there are multiple infectious disease outbreaks (defined as the occurrence of cases of disease in excess of what is expected) throughout the world. Some of these become severe and have global and domestic implications, including, most notably, the COVID-19 pandemic, but also the 2002-2004 SARS outbreak in China and eventually 28 other countries and the 2014 Ebola outbreak in West Africa. Since outbreaks are an ongoing reality and threat to human health, understanding the current status and scope of global disease outbreaks is important for stemming further spread to other geographic areas and populations, providing advice to travelers, and identifying the types of medical countermeasures that might be needed. While historically the U.S. government has played a key and often lead role in responding to outbreaks throughout the world, particularly in low- and middle-income countries, understanding the extent of outbreaks takes on added importance now, given changes made by the Trump administration. These changes include reduced funding, reductions in the number of U.S. staff supporting international outbreak response efforts, and elimination of some offices and functions, actions which collectively have diminished current U.S. government capacity to respond to outbreaks at home and abroad, even as experts believe another costly pandemic may strike the world within 25 years. There may a renewed opportunity, however, to mitigate some of these risks with the release of the State Department’s new U.S. global health strategy, which includes global health security as one of its three pillars.

To better understand the current outbreak landscape around the world, and because there is no single database of all global outbreaks, we analyzed data from multiple official sources to develop a snapshot of the number, type, and location of disease outbreaks, with human transmission, that have occurred thus far in 2025. Based on this analysis, we identified more than 100 outbreaks, including some that have affected multiple countries and impacted large populations. This finding is broadly similar to an estimate from a prior study of the 1996-2023 period that identified an average of 108 outbreaks that occurred each year. However, given that 2025 is not yet over, there could be more outbreaks in the weeks and months ahead. Our finding is also likely an underestimate due to delays in reporting and other factors (see methods for more information).

Findings

Our analysis finds that thus far in 2025 (see Table 1):

  • We identified 102 reported disease outbreaks with human transmission in 66 countries as of October 10, 2025; this is likely an undercount due to delays in reporting, the multiplicity of outbreaks that may be captured in this analysis as a single outbreak (e.g., the United States has identified 44 distinct outbreaks of measles as of Oct. 7 this year), and other factors.
  • These outbreaks are due to 20 different infectious diseases spanning a wide variety of disease types (including respiratory, vector-borne, food or waterborne, and direct contact infections) and including avian influenza (H5N1), Chikungunya, cholera, Ebola, Marburg, measles, mpox, Nipah, Rift Valley fever, yellow fever, and Zika, among others.
  • There is significant geographic variation in the occurrence of outbreaks by region. The greatest number of reported outbreaks have been in sub-Saharan Africa (33 countries), followed by the Western Hemisphere (15), East Asia and the Pacific (7), South and Central Asia (6), and the Near East (Middle East and North Africa, 5).
  • A third of these countries (23) countries have experienced more than one outbreak this year, often of varying scales. For example, the Democratic Republic of the Congo has reported outbreaks of anthrax, cholera, cVDPV1, Ebola virus disease, mpox, and one outbreak due to an unexplained cause but described now as “acute febrile illness,” and the United States has reported outbreaks of dengue – which is not endemic in the continental U.S. but has caused localized transmission from travel-related imported cases – and measles, which had long been considered eliminated in the U.S., a status that is now at risk due to increasing cases.
  • Outbreaks have ranged in size, as measured by number of cases as well as the number of affected countries. For example, a single case of Chapare hemorrhagic fever constituted an outbreak in Bolivia, while the largest this year has been the cholera outbreak across 34 countries, which has approached a half million cases and been declared a health emergency by the World Health Organization.
  • Similarly, the number of deaths resulting from these outbreaks has also varied widely, as some virulent infectious diseases have led to high mortality, such as deaths among all suspected cases of Marburg virus disease (10 of 10) and deaths among two-thirds of suspected cases of Ebola virus disease (43 of 64). Others have resulted in few deaths but spread rapidly and can have important health impacts, such as chikungunya and mpox.

Table 1

Disease Outbreaks, 2025

DiseaseCountryRegion*Primary Category for Disease/TransmissionNumber of Cases/Deaths (as of date)
Acute febrile illnessDemocratic Republic of the CongoSub-Saharan AfricaNot applicable1,318 suspected cases, inc. 53 deaths (as of Feb. 25)
AnthraxDemocratic Republic of the CongoSub-Saharan AfricaDirect contact infection17 suspected cases, inc. 1 death (as of April 30)
ThailandEast Asia and the Pacific5 confirmed cases, inc. 1 death (as of May 28)
UgandaSub-Saharan Africa15 confirmed cases, inc. 2 deaths (as of March 30)
Avian InfluenzaCambodiaEast Asia and the PacificRespiratory infectionCambodia: 11 confirmed cases, inc. 6 deaths (as of July 1)
Mexico: 1 confirmed case, inc. 1 death (as of April 2)
MexicoWestern Hemisphere
Chapare hemorrhagic feverBoliviaWestern HemisphereDirect contact infection1 confirmed case, inc. 1 death (as of Jan. 13)
ChikungunyaKey countries:
Bangladesh
South and Central AsiaVector-borne infectionGlobal overview: 445,271 (263,592 suspected and 181,679 confirmed) cases, inc. 155 deaths (as of Sept. 30)
Indian Ocean countries: data not provided (as of Sept. 5)
Bolivia: data not provided (as of June 26)
Cuba: data not provided (as of Sept. 26)
La Réunion and Mayotte (France): in La Réunion, over 47,500 confirmed cases, but more than 170,000 consultations for suspected chikungunya, and at least 12 deaths, with more suspected; in Mayotte, 116 cases (as of May 4)
BoliviaWestern Hemisphere
ChinaEast Asia and the Pacific
CubaWestern Hemisphere
KenyaSub-Saharan Africa
La Réunion and Mayotte (France)Sub-Saharan Africa
MadagascarSub-Saharan Africa
SomaliaSub-Saharan Africa
Sri LankaSouth and Central Asia
CholeraAfghanistanSouth and Central AsiaFood-/waterborne infectionGlobal overview: 489,452 cholera/Acute Watery Diarrhea cases; 6,155 deaths (as of Sept. 26; earlier alert)
AngolaSub-Saharan Africa
BangladeshSouth and Central Asia
BurundiSub-Saharan Africa
ChadSub-Saharan Africa
Cote d’IvoireSub-Saharan Africa
Democratic Republic of the CongoSub-Saharan Africa
EthiopiaSub-Saharan Africa
GhanaSub-Saharan Africa
HaitiWestern Hemisphere
IndiaSouth and Central Asia
IraqNear East
KenyaSub-Saharan Africa
MalawiSub-Saharan Africa
MozambiqueSub-Saharan Africa
MyanmarEast Asia and the Pacific
NamibiaSub-Saharan Africa
NepalSouth and Central Asia
NigerSub-Saharan Africa
NigeriaSub-Saharan Africa
PakistanSouth and Central Asia
PhilippinesEast Asia and the Pacific
Republic of the CongoSub-Saharan Africa
RwandaSub-Saharan Africa
SomaliaSub-Saharan Africa
South SudanSub-Saharan Africa
SudanSub-Saharan Africa
TanzaniaSub-Saharan Africa
ThailandEast Asia and the Pacific
TogoSub-Saharan Africa
UgandaSub-Saharan Africa
YemenNear East
ZambiaSub-Saharan Africa
ZimbabweSub-Saharan Africa
DengueUnited States of AmericaWestern HemisphereVector-borne infectionOutbreaks in various areas (as of July 29); 2,560 locally acquired cases (as of Sept. 25)
Ebola virus disease (EVD) (inc. Sudan virus disease, SVD)Democratic Republic of the Congo

Uganda
Sub-Saharan AfricaDirect contact infectionEVD: 64 suspected (53 confirmed and 11 probable) cases, inc. 43 deaths (as of Oct. 5; earlier alert)

SVD: 14 cases – 12 confirmed, 2 probable – inc. 4 deaths – 2 confirmed, 2 probable (as of April 26)
Invasive meningococcal diseaseSaudi ArabiaNear EastDirect contact infection17 cases (as of April 11)
Marburg virus disease TanzaniaSub-Saharan AfricaDirect contact infection10 suspected (2 confirmed, 8 probable) cases, inc. 10 deaths (as of March 12)
MeaslesArgentinaWestern HemisphereRespiratory infectionRegion of the Americas (inc. United States of America): 10,139 confirmed cases, inc. 18 deaths (as of Aug. 8; earlier alert)
Morocco: more than 25,000 suspected cases, inc. 13,706 confirmed cases and 184 deaths, from Oct. 2023 through April 13, 2025 (as of May 13)
United States of America: 1,544 cases, inc. 3 deaths (as of Sept. 30)
BelizeWestern Hemisphere
BoliviaWestern Hemisphere
BrazilWestern Hemisphere
CanadaWestern Hemisphere
Costa RicaWestern Hemisphere
MexicoWestern Hemisphere
MoroccoNear East
ParaguayWestern Hemisphere
PeruWestern Hemisphere
United States of AmericaWestern Hemisphere
Middle East respiratory syndrome (MERS) coronavirusSaudi ArabiaNear EastRespiratory infection9 confirmed cases, inc. 2 deaths (as of April 21)
MpoxKey countries:
Burundi
Democratic Republic of the Congo
Kenya
Rwanda
Sierra Leone
Uganda
Sub-Saharan AfricaDirect contact infectionGlobal overview: 38,671 confirmed cases, inc. 163 deaths (as of Aug. 31; earlier alert)
Nipah virusBangladesh
India
South and Central AsiaDirect contact infectionBangladesh: 4 confirmed cases, inc. 4 deaths (as of Aug. 29)
India: 4 confirmed cases, inc. 2 deaths (as of July 12)
Oropouche virus diseaseKey countries:
Brazil
Panama
Western HemisphereVector-borne infectionData not provided (as of July 14); Americas Region overview: 12,786 confirmed cases (as of July 27)
RabiesTimor-LesteEast Asia and the PacificDirect contact infection4 confirmed cases, inc. 4 deaths (as of June 17)
Rift Valley FeverSenegalSub-Saharan AfricaVector-borne infectionData not provided (as of Oct. 10)
Variant Poliovirus (i.e., circulating vaccine-derived poliovirus of three types: cVDPV1, cVDPV2, cVDPV3)cVDPV1:
Algeria
Near EastFood-/waterborne infectioncVDPV1 global overview: 2 cases of acute flaccid paralysis (as of Oct. 6)
 
cVDPV2 global overview: 146 cases of acute flaccid paralysis (as of Oct. 6)
 
cVDPV3 global overview: 5 cases of acute flaccid paralysis (as of Oct. 6)
Democratic Republic of the CongoSub-Saharan Africa
cVDPV2:
Angola
Sub-Saharan Africa
BeninSub-Saharan Africa
Burkina FasoSub-Saharan Africa
Central African RepublicSub-Saharan Africa
ChadSub-Saharan Africa
DjiboutiSub-Saharan Africa
EthiopiaSub-Saharan Africa
NigerSub-Saharan Africa
NigeriaSub-Saharan Africa
Papua New GuineaEast Asia and the Pacific
SomaliaSub-Saharan Africa
SudanSub-Saharan Africa
YemenNear East
cVDPV3:
Cameroon
Sub-Saharan Africa
ChadSub-Saharan Africa
GuineaSub-Saharan Africa
Yellow fever Bolivia
Brazil
Colombia
Ecuador
Peru
Western HemisphereVector-borne infection235 confirmed cases, inc. 96 deaths (as of May 25; earlier alert)
Zika virus diseaseIndiaSouth and Central AsiaVector-borne infection151 cases in 2024 (as of Jan. 29)
Note: * Regions reflect those used by the U.S. State Department; Near East includes the Middle East and North Africa. Disease outbreaks as identified and defined by the following authoritative sources: WHO, CDC, and GPEI; not an exhaustive list of outbreaks globally. As of Oct. 10, 2025. Does not include diseases such as COVID-19, wild poliovirus, and seasonal influenza where there have not been unexpected levels of cases and deaths this year.

Sources: WHO, Disease Outbreak News, Situation Reports, and Rapid Risk Assessment Reports; CDC, Outbreak webpage; CDC, Travel Notices webpage; GPEI, Polio This Week.

Methods

This analysis is based on data from the World Health Organization (WHO: Disease Outbreak News, Situation Reports, and Rapid Risk Assessment Reports); U.S. Centers for Disease Control and Prevention (CDC: Outbreak webpage and Travel Notices webpage), and the Global Polio Eradication Initiative (GPEI: Polio This Week), with some supplementary data obtained from the Pan American Health Organization (PAHO). Case reports and data from these sources were used to identify outbreaks with human transmission (including transmission from animal to human) by country and type as of October 10, 2025. This estimate should be considered a floor. First, one or more outbreaks of a single disease reported in a particular country are counted as a single outbreak – for example, the United States has identified 44 distinct outbreaks of measles as of Oct. 7 this year, but it is included as a single outbreak in this analysis. Second, due to delays in reporting and non-reporting (due to capacity or other issues), not all outbreaks that have occurred have necessarily been reported to these sources. Third, not included in this analysis are diseases that may be significant and with ongoing transmission, including this year, but not reported to be occurring at unexpected levels, such as COVID-19, seasonal influenza, and wild poliovirus; also not included are diseases that are spreading among animals without transmission to humans. Finally, while the sources used are the main international sources available for tracking outbreaks, there may be other sources that capture additional data (such as ProMED from the International Society for Infectious Diseases, BEACON based at Boston University, and The Tracking Report based at Brown University).